Healthcare / Medical Care FacilitiesShenzhen
$17.11
-0.67 (-3.77%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 24%
FCF escenarios
weak_data · normalized FCF $39.3M · quality 63.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
41/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.7B
P/E
100.6x
↑EV/EBITDA
13.9x
↑ROE
1.5%
↑Gross Margin
41.0%
↓Debt/Equity
0.09
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+4.6%
FCF CAGR
+7.6%
FCF margin
11.3%
FCF / Net income
4.51x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.09B · net income $27.3M · FCF $123.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.09B | $1.09B | $1.10B | $1.19B | $955.3M |
| Net Income | $27.3M | $27.3M | $-27.4M | $63.6M | $32.6M |
| EBITDA | $167.7M | $167.7M | $124.7M | $229.7M | $188.8M |
| EPS | 0.17 | 0.17 | -0.17 | 0.40 | 0.22 |
| Gross Margin | 41.0% | 41.0% | 38.6% | 41.8% | 38.4% |
| Operating Margin | 4.6% | 4.6% | -0.1% | 7.4% | 6.7% |
| Net Margin | 2.5% | 2.5% | -2.5% | 5.4% | 3.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.09 | 0.09 | 0.12 | 0.12 | 0.13 |
| Current Ratio | 8.52 | 8.52 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $123.2M | $123.2M | $39.3M | $-11.7M | $98.9M |
| Returns | |||||
| ROE | 1.5% | 1.5% | -1.5% | 3.1% | 1.5% |
| Valuation | |||||
| P/E | 100.65 | 100.65 | — | 71.95 | 154.61 |
| EV/EBITDA | 13.89 | 13.89 | 19.89 | 14.12 | 19.52 |
| P/B | 1.44 | 1.44 | 1.61 | 2.20 | 2.32 |
| Growth & Yield | |||||
| Revenue Growth | -0.3% | -0.3% | -7.6% | 24.1% | — |
| EPS Growth | 199.8% | 199.8% | -143.1% | 82.7% | — |
| Dividend Yield | 0.8% | 0.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
106.3%
EPS terminal req.
$1.52
Spread vs growth
93.5%
5Y implied EPS CAGR
60.4%
EPS terminal req.
$1.84
Spread vs growth
139.4%
10Y implied EPS CAGR
32.8%
EPS terminal req.
$2.96
Spread vs growth
166.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-18.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.17 → 0.17
Residual
-19.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.